Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel 1H-Pyrrolo[3,2-c]quinoline Based 5-HT6 Receptor Antagonists with Potential Application for the Treatment of Cognitive Disorders Associated with Alzheimer’s Disease
Katarzyna Grychowska, Grzegorz Satała, Tomasz Kos, et al.
ACS Chemical Neuroscience (2016) Vol. 7, Iss. 7, pp. 972-983
Open Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Missing-linker defects in a covalent organic framework photocatalyst for highly efficient synthesis of tetrahydroquinoline
Yuling Zhao, Kangna Zhang, Keping Zhu, et al.
Green Chemistry (2024) Vol. 26, Iss. 5, pp. 2645-2652
Closed Access | Times Cited: 49
Progress in Investigational Agents Targeting Serotonin-6 Receptors for the Treatment of Brain Disorders
Ramakrishna Nirogi, Pradeep Jayarajan, Anil Shinde, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 309-309
Open Access | Times Cited: 30
First-in-Class Selenium-Containing Potent Serotonin Receptor 5-HT6 Agents with a Beneficial Neuroprotective Profile against Alzheimer’s Disease
Patryk Pyka, Wawrzyniec Haberek, Małgorzata Więcek, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 1580-1610
Open Access | Times Cited: 13
Physical interaction between neurofibromin and serotonin 5-HT 6 receptor promotes receptor constitutive activity
Wissem Deraredj Nadim, Séverine Chaumont‐Dubel, Fahima Madouri, et al.
Proceedings of the National Academy of Sciences (2016) Vol. 113, Iss. 43, pp. 12310-12315
Open Access | Times Cited: 82
Imidazopyridine-based selective and multifunctional ligands of biological targets associated with psychiatric and neurodegenerative diseases
David Vanda, Paweł Zajdel, Miroslav Soural
European Journal of Medicinal Chemistry (2019) Vol. 181, pp. 111569-111569
Closed Access | Times Cited: 75
Antagonism of the 5-HT 6 receptor – Preclinical rationale for the treatment of Alzheimer's disease
Inge E.M. de Jong, Arne Mørk
Neuropharmacology (2017) Vol. 125, pp. 50-63
Closed Access | Times Cited: 70
Constitutive activity of 5-HT receptors: Factual analysis
Philippe De Deurwaerdère, Rahul Bharatiya, Abdeslam Chagraoui, et al.
Neuropharmacology (2020) Vol. 168, pp. 107967-107967
Open Access | Times Cited: 52
Porphyrin covalent organic framework for photocatalytic synthesis of tetrahydroquinolines
Chengjuan Wu, Xinyu Li, Ming‐Zhen Shao, et al.
Chinese Chemical Letters (2022) Vol. 33, Iss. 10, pp. 4559-4562
Closed Access | Times Cited: 37
Synthesis, DFT studies on a series of tunable quinoline derivatives
Nagesh Dhanaji Chavan, V. Vijayakumar
RSC Advances (2024) Vol. 14, Iss. 29, pp. 21089-21101
Open Access | Times Cited: 8
The 1,3,5-Triazine Derivatives as Innovative Chemical Family of 5-HT6 Serotonin Receptor Agents with Therapeutic Perspectives for Cognitive Impairment
Gniewomir Latacz, Annamaria Lubelska, Magdalena Jastrzębska‐Więsek, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 14, pp. 3420-3420
Open Access | Times Cited: 50
The 5-HT6 receptor interactome: New insight in receptor signaling and its impact on brain physiology and pathologies
Séverine Chaumont‐Dubel, Vincent Dupuy, Joël Bockaert, et al.
Neuropharmacology (2019) Vol. 172, pp. 107839-107839
Open Access | Times Cited: 48
Biological properties of pyrroloquinoline and pyrroloisoquinoline derivatives
Petra Králová, Miroslav Soural
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116287-116287
Closed Access | Times Cited: 5
A new serotonin 5-HT6 receptor antagonist with procognitive activity – Importance of a halogen bond interaction to stabilize the binding
Juan A. González‐Vera, Rocío A. Medina, Mar Martín‐Fontecha, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 45
Novel non-sulfonamide 5-HT 6 receptor partial inverse agonist in a group of imidazo[4,5- b ]pyridines with cognition enhancing properties
David Vanda, Miroslav Soural, Vittorio Canale, et al.
European Journal of Medicinal Chemistry (2017) Vol. 144, pp. 716-729
Closed Access | Times Cited: 44
Metal-Free Radical [2 + 2 + 1] Cyclization of ortho-Cyanoarylacrylamides with Alkyl Nitriles: Synthesis of Pyrrolo[3,2-c]quinolines
Tao Yang, Wen‐Jin Xia, Jia-Qi Shang, et al.
Organic Letters (2018) Vol. 21, Iss. 2, pp. 444-447
Closed Access | Times Cited: 44
Solvent-free and room temperature visible light-induced C–H activation: CdS as a highly efficient photo-induced reusable nano-catalyst for the C–H functionalization cyclization of t-amines and C–C double and triple bonds
Somayeh Firoozi, Mona Hosseini‐Sarvari, Mehdi Koohgard
Green Chemistry (2018) Vol. 20, Iss. 24, pp. 5540-5549
Closed Access | Times Cited: 43
Virtual screening-driven discovery of dual 5-HT6/5-HT2A receptor ligands with pro-cognitive properties
Jakub Staroń, Rafał Kurczab, Dawid Warszycki, et al.
European Journal of Medicinal Chemistry (2019) Vol. 185, pp. 111857-111857
Open Access | Times Cited: 36
Sulfur-containing therapeutics in the treatment of Alzheimer’s disease
Haizhou Zhu, Venkateshwara Dronamraju, Wei Xie, et al.
Medicinal Chemistry Research (2021) Vol. 30, Iss. 2, pp. 305-352
Open Access | Times Cited: 31
SAR studies of quinoline and derivatives as potential treatments for Alzheimer’s disease
Zhaohui Li, Liquan Yin, Donghai Zhao, et al.
Arabian Journal of Chemistry (2022) Vol. 16, Iss. 2, pp. 104502-104502
Open Access | Times Cited: 20
Recent Advances in Domino Synthesis of Fused Polycyclic N‐Heterocycles Based on Intramolecular Alkyne Hydroamination under Copper Catalysis
Zefeng Jin, Guodong Shen, Xin Lv
Chinese Journal of Chemistry (2023) Vol. 41, Iss. 24, pp. 3751-3771
Closed Access | Times Cited: 11
Dual-acting agents for improving cognition and real-world function in Alzheimer’s disease: Focus on 5-HT6 and D3 receptors as hubs
Mark J. Millan, Anne Dekeyne, Alain P. Gobert, et al.
Neuropharmacology (2020) Vol. 177, pp. 108099-108099
Open Access | Times Cited: 31
Dual 5-HT6 and D3 Receptor Antagonists in a Group of 1H-Pyrrolo[3,2-c]quinolines with Neuroprotective and Procognitive Activity
Katarzyna Grychowska, Séverine Chaumont‐Dubel, Rafał Kurczab, et al.
ACS Chemical Neuroscience (2019) Vol. 10, Iss. 7, pp. 3183-3196
Open Access | Times Cited: 30
mTOR activation by constitutively active serotonin6 receptors as new paradigm in neuropathic pain and its treatment
Pierre-Yves Martin, Stéphane Doly, Al Mahdy Hamieh, et al.
Progress in Neurobiology (2020) Vol. 193, pp. 101846-101846
Open Access | Times Cited: 28
Superiority of the Triple-Acting 5-HT6R/5-HT3R Antagonist and MAO-B Reversible Inhibitor PZ-1922 over 5-HT6R Antagonist Intepirdine in Alleviation of Cognitive Deficits in Rats
Katarzyna Grychowska, Uriel López-Sánchez, Mathieu Vitalis, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 21, pp. 14928-14947
Open Access | Times Cited: 10
Compound PZ-1262, a 4-isoquinoline-sulfonamide analog of Brexpiprazole, produces potential antidepressant, anxiolytic and procognitive effects in rodent models
Anna Partyka, Joanna Gołębiowska, Krzysztof Marciniec, et al.
Pharmacological Reports (2025)
Closed Access
Page 1 - Next Page

Scroll to top